DEA's ALJ Rules in Favor of MMJ Advocates!!

As we all know, the DEA has made it extremely difficult for research of medical marijuana to take place. I mean, why would they want the scientific community to prove them wrong and improve the lives of suffering Americans?

Luckily, or rather sensibly, on Feb 12 the DEA's own Administrative Law Judge (ALJ) ruled that the DEA has been improperly blocking the needed research of medical marijuana that could help save lives. The decision came after MPP's grant program funded a lawsuit against the DEA.

Here's what happened:
Professor Lyle Craker of the University of Massachusetts at Amherst, working in conjunction with the Multidisciplinary Association for Psychedelic Studies, has been trying for years to solve this problem. Back in 2001, he applied to the DEA for permission to grow a private supply of marijuana for use in clinical research. The DEA delayed making a decision for nearly three and a half years and then finally rejected Dr. Craker’s application, fallaciously claiming that international treaty obligations prevented it from granting permission.
DEA ALJ Mary Ellen Bittner ruled that the DEA had no basis to reject Dr. Craker’s application. Read her ruling here.

----------------------
Quite a message to send to the DEA and Karen Tandy in particular. Hopefully she'll come around and listen to science... naaaaaaaaaah.